Stronger Sell Today ACOR ranks #5782 as SELL CANDIDATE #5782 Weaker Sell

ACOR stock forecast Acorda Therapeutics

ACOR stock forecast

VOLUME
Buy
TREND
Sell
MV LONG
Sell

MV SHORT
Sell

PIVOT
Sell

MACD
Buy

Social Sentiment for ACOR

Today's data is from 1 opinions on StockTwits provided by IEX Cloud.
Bullish vs. Bearish opinions
100%
0%
Weighted Sentiment 0.70

Will ACOR stock price go up or down on Tue, 28 May 2019?

Predict

Acorda Therapeutics Forecast and Stock Analysis

Technical ACOR stock analysis for Thursday May 23, 2019.

Sell candidate since 2019-05-07 Loss -11.61%
Shorts n/a
Insider % n/a
Institutional % n/a
Beta 1.50
ROA -0.49%
Price to book USD 0.93
P/E Ratio -93.47
Next Earnings Date 2019-08-01


Acorda Therapeutics fell by -6.29% in the last day ( Thursday, 23rd May 2019 ) from $10.97 to $10.28 During day the stock fluctuated 8.56% from a day low at $10.11 to a day high of $10.97. The price has been going up and down for this period, and there has been a -11.53% loss for the last 2 weeks. Volume has increased in the last day by 230 183 shares, but on falling prices. This may be an early warning and the risk will be increased slightly for the next couple of days. In total, 825 728 shares bought and sold for approximately $8.49 million.

Quick summary:

  • 30 day high of the ACOR stock price was $12.15 and low was $9.58.
  • 90 day high was $15.41 and low was $9.58.
  • 52 week high for the Acorda Therapeutics - $36.35 and low - $9.58.

Trend

Acorda Therapeutics lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -27.26% during the next 3 months and, with 90% probability hold a price between $6.51 and $8.25 at the end of this period.

Click here for today's Top 5 Trending Companies

Signals

There are few to none technical positive signals at the moment. Acorda Therapeutics holds sales signals from both short- and long-term moving averages. In addition, there is a general sales signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up there will be some resistance from the lines at $10.97 and $11.50. A break-up above any of these levels will issue buy signals. A sales signal was issued from a pivot top point on Wednesday May 22, 2019, which indicates further falls until a new bottom pivot has been found. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Access today's Top 5 Golden Star Companies

Relative Strength Index (RSI)

RSI14 is 33 and the stock is currently not being overbought or oversold

Access full RSI 14 and RSI 21 lists

Support & Resistance

Acorda Therapeutics finds support from accumulated volume at $10.05.

Support: $10.05 Price: $10.28 Resistance: $10.58

Risk

This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.87 between high and low, or 8.56%. For the last week, the stock has had a daily average volatility of 5.35%.

Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.

5.35 %

Average volatility

Overall risk:

Very Low Low Medium High Very High

Evaluation:

Acorda Therapeutics holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our recommendation for this stock since last evaluation from a Sell Candidate to a Strong Sell Candidate.

Strong Sell Candidate Downgraded
Stronger Sell Today ACOR ranks #5782 as SELL CANDIDATE #5782 Weaker Sell
ACOR $10.28 ($-0.69 -6.29%)
ACOR is down $0.69 today, but where's it headed in 2019?
Zacks Investment Research is releasing its prediction for ACOR based on the 1-3 month system that more than doubles the S&P 500.

This report is free today for StockInvest.us readers.

Click here – the ACOR analysis is free »

Will ACOR stock price go up or down
on Tue, 28 May 2019?

Predict

Proudly made at

Rise Vilnius
in partnership with
Barclays Bank